This is not the most recent version of the article. View current version (12 MAY 2010)

Intervention Protocol

Beta-interferon for chronic hepatitis B

  1. Humberto Saconato1,*,
  2. Álvaro N Atallah2,
  3. G M Souza3,
  4. Eduardo R Parise4

Editorial Group: Cochrane Hepato-Biliary Group

Published Online: 22 APR 2002

DOI: 10.1002/14651858.CD003622


How to Cite

Saconato H, Atallah ÁN, Souza GM, Parise ER. Beta-interferon for chronic hepatitis B (Protocol). Cochrane Database of Systematic Reviews 2002, Issue 2. Art. No.: CD003622. DOI: 10.1002/14651858.CD003622.

Author Information

  1. 1

    Federal University of Rio Grande do norte, Department of Medicine, São Paulo, Vila Clementino, Brazil

  2. 2

    Universidade Federal de São Paulo / Escola Paulista de Medicina, Brazilian Cochrane Centre, São Paulo, SP, Brazil

  3. 3

    Federal University of São Paulo, Sao Paulo, Brazil

  4. 4

    Federal University of São Paulo, Gastroenterology, São Paulo, Brazil

*Humberto Saconato, Department of Medicine, Federal University of Rio Grande do norte, Alameda jauaperi 1083, São Paulo, Vila Clementino, 04523-014, Brazil. hsaconato@uol.com.br. hsaconato@yahoo.com.br.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 22 APR 2002

SEARCH

This is not the most recent version of the article. View current version (12 MAY 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To evaluate the beneficial and harmful effects of beta-interferon in the treatment of chronic hepatitis B in adults and children.